Washington University Medical Center
Welcome,         Profile    Billing    Logout  
 10 Trials 
16 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Piccirillo, Jay F
SNORE-LESS, NCT05756647: Mandibular Advancement vs Home Treatment for Primary Snoring

Completed
2
120
US
Interventional Arm, MAD (anti-snoring mouthpiece), Conservative treatment Arm
Washington University School of Medicine
Snoring
07/23
07/23
GRACE, NCT05184192: Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction

Completed
2
76
US
Gabapentin gelatin capsules 300mg, Letco, Placebo
Washington University School of Medicine
COVID-19, Olfactory Disorder, Anosmia, Hyposmia, Parosmia
08/23
08/23
LAFF, NCT06429501: Local Anesthesia for Facial Fractures

Recruiting
2
70
US
Bupivacaine/Epinephrine, Saline
Washington University School of Medicine
Pain Management
07/25
07/25
NCT05947643: Smell in COVID-19 and Efficacy of Nasal Theophylline (SCENT 3)

Active, not recruiting
2
41
US
theophylline, Placebo, inactive medicine
Washington University School of Medicine
COVID-19
04/24
08/24
Tran, David
TVI-AST-008, NCT05685004: Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)

Recruiting
2/3
120
US
TVI-Brain-1, Standard of Care, Radiotherapy, Temozolomide, Chemotherapy
TVAX Biomedical
Glioblastoma Multiforme of Brain
12/26
03/27
EMPOWER, NCT04333706: A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease

Recruiting
1/2
65
US
Capecitabine, Sarilumab 150mg or 200 mg plus Capecitabine, Sarilumab 150mg plus Capecitabine
University of Southern California, National Cancer Institute (NCI)
Breast, Metastatic, Triple Negative, Cancer, Disseminated Tumor Cell
11/25
11/26
TORCH, NCT04187872: LITT and Pembrolizumab in Recurrent Brain Metastasis

Terminated
1
10
US
LITT + Pembrolizumab, NeuroBlate System, Keytruda
University of Florida, Monteris Medical
Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC), Small-cell Lung Cancer, Head and Neck Squamous Cell Cancer, Classical Hodgkin Lymphoma, Primary Mediastinal Large B-Cell Lymphoma, Urothelial Carcinoma, Microsatellite Instability-High Cancer, Gastric Cancer, Esophageal Cancer, Cervical Cancer, Hepatocellular Carcinoma, Merkel Cell Carcinoma, Brain Metastases, Adult
12/23
12/23
DCVax-L EAP, NCT02146066: Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221

Available
N/A
US
DCVax-L
Northwest Biotherapeutics
GBM, Glioblastoma Multiforme
 
 
Chakinala, Murali
NCT03626688 / 2018-001187-33: A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

Recruiting
3
1000
Europe, Canada, US, RoW
Ralinepag, APD811, Placebo
United Therapeutics
PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension, Connective Tissue Diseases, Familial Primary Pulmonary Hypertension, Vascular Diseases, Cardiovascular Diseases, Hypertension, Pulmonary, Lung Diseases, Respiratory Tract Disease
12/25
12/25
NCT03850964: Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)

Recruiting
2/3
70
US
Pazopanib, Votrient, Placebo oral capsule, cellulose capsule
Cure HHT, United States Department of Defense, Food and Drug Administration (FDA)
Hereditary Hemorrhagic Telangiectasia, Epistaxis, Anemia, Nosebleed, HHT
09/25
10/26
ELEVATE 2, NCT04712669 / 2020-004971-42: A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension

Completed
2
108
Europe, Canada, US, RoW
rodatristat ethyl 300 mg tablet BID, rodatristat ethyl 600 mg BID, Placebo
Altavant Sciences GmbH
Pulmonary Arterial Hypertension
06/23
08/23
CHORUS, NCT06259292: Comprehensive HHT Outcomes Registry of the United States

Recruiting
N/A
10000
US
Cure HHT, Augusta University, The Cleveland Clinic, Mayo Clinic, Massachusetts General Hospital, Columbia University, Oregon Health and Science University, University of California, Los Angeles, University of California, San Francisco, University of Colorado, Denver, University of North Carolina, Chapel Hill, University of Pennsylvania, University of Texas, University of Utah, Washington University School of Medicine, Yale University, Health Resources and Services Administration (HRSA), Children's Hospital of Philadelphia
Hereditary Hemorrhagic Telangiectasia, Arteriovenous Malformations, Telangiectasia, Epistaxis, GastroIntestinal Bleeding, Cerebral Arteriovenous Malformations, Vascular Malformation
11/33
11/33
BVMN6203, NCT01158807: Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia

Recruiting
N/A
1800
Europe, Canada, US
Unity Health Toronto, National Institute of Neurological Disorders and Stroke (NINDS)
Hereditary Hemorrhagic Telangiectasia
12/24
06/25
PHAR, NCT04071327: Pulmonary Hypertension Association Registry

Recruiting
N/A
3000
US
Pulmonary Hypertension Association, Inc., University of Washington, the Collaborative Health Studies Coordinating Center
Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Hypertension
10/25
10/25
Fontana, Luigi
V-CHECK, NCT05847387: The Viability Control of Human Endothelial Cells Before Keratoplasty () Study

Recruiting
N/A
135
Europe
V-Check
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Corneal Transplant Failure, Corneal Endothelial Cell Loss
09/24
09/25
Lasala, John
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
01/25
04/30
Kuan, Anne
No trials found
Ochsner, Lisa
No trials found

Download Options